Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/dYjpCfbwocePxgoZxsqN

  ADVERTISEMENT  
October 31, 2012
Sign upForwardArchiveAdvertise
News for diabetes health professionals

  Diabetes in Focus 
  • Insulin analog shows blood glucose potential in trial
    Data from a midstage trial revealed the basal insulin analog LY2605541 showed blood glucose benefits comparable to those of insulin glargine but fared better in reducing patients' weight and variability in glucose readings. Researchers also found the new agent helped lessen the frequency of nocturnal hypoglycemia by 48% compared with glargine. The findings appear in Diabetes Care. Modern Medicine/Reuters (10/30) LinkedInFacebookTwitterEmail this Story
  • Gaining weight after diabetes diagnosis raises mortality risk
    Weight gain in the first year following type 2 diabetes diagnosis was associated with an increased risk of cardiovascular and all-cause mortality, according to a Swedish study presented at the European Association for the Study of Diabetes annual meeting. Data on nearly 8,500 patients showed the rates of cardiovascular and all-cause mortality were 63% and 34% higher, respectively, in patients who gained weight compared with those who didn't gain weight. Family Practice News (10/30) LinkedInFacebookTwitterEmail this Story
  • Resveratrol does not boost metabolic markers in women
    Nonobese, postmenopausal women with normal glucose tolerance who took resveratrol supplements had increased plasma resveratrol concentration but did not show improvements in plasma lipids, insulin sensitivity or inflammatory markers, researchers reported in Cell Metabolism. Resveratrol supplementation also did not impact putative targets in muscle or fat. PhysiciansBriefing.com/HealthDay News (10/30) LinkedInFacebookTwitterEmail this Story
  • Study: Intravitreal shots improve visual acuity in DME
    Data on 953 patients with persistent diabetic macular edema showed 28.7% of those receiving low-dose and 27.8% getting high-dose fluocinolone acetonide intravitreal injections attained significant improvements in best corrected visual acuity of ≥ 15 letters, compared with 18.9% in the sham injection group. The results were published in the journal Ophthalmology. Healio/OSN Retina (10/30) LinkedInFacebookTwitterEmail this Story
  Nutrition & Wellness 
  • Review examines maternal, childhood risk factors for overweight
    Mothers' smoking during pregnancy raised children's risk of being overweight by almost 48%, a review in the journal Archives of Disease in Childhood found. Researchers noted that a high birth weight and fast weight gain during the initial year of life also increased the risk of children being overweight. Breast-feeding and late weaning lowered that risk. HealthDay News (10/30) LinkedInFacebookTwitterEmail this Story
  • Study looks at obesity risk factors among students
    A study presented at the American Public Health Association annual meeting revealed drinking soda and having a sedentary lifestyle increase the risk of obesity among students, but eating more meals per day and playing school sports lower the risk. Researchers, who were evaluating a school-based program, also found children at poorer schools were more likely to be overweight and gain more weight, compared with students at schools with a higher socioeconomic status. HealthDay News (10/30) LinkedInFacebookTwitterEmail this Story
  • People who exercise before breakfast burn more fat
    Men who exercised before eating breakfast burned 33% more fat compared with those who exercised after breakfast, according to a study in the British Journal of Nutrition. Exercising on an empty stomach was also associated with greater reductions in artery-clogging blood fats, researchers noted. Yahoo/Asian News International (10/30) LinkedInFacebookTwitterEmail this Story
  Practice Update 
  • Clinicians use smartphones to view EHRs only, report says
    Data from research firm KLAS showed 70% of clinicians use their smartphones or tablets to look up EHRs but don't enter any information because it is too difficult to do so using a small screen. The report authors said many clinicians are concerned that mobile applications don't show all of the relevant patient information they need. Medscape (free registration) (10/29) LinkedInFacebookTwitterEmail this Story
  Trends & Technology 
  • KnowMe initiative uses wearable device to encourage activity
    The KnowMe Networks project has created a wireless device to help minority youths track their metabolic health, physical activity and vital signs. The data is sent, using Bluetooth-enabled sensors, to smartphones and can be shared with caregivers. Researchers also were able to send text messages to youths who had been sedentary for long periods of time, encouraging them to get up and be active. MobiHealthNews.com (10/29) LinkedInFacebookTwitterEmail this Story
  ADA News 
  • Free CME Self-Assessment Program on Microvascular Complications
    This self-assessment program consists of clinical problem-solving multiple-choice questions and educational critiques. It is designed to objectively assess and strengthen your knowledge of diabetes and provide you with a better understanding of the diagnosis, management and treatment of microvascular complications. Credit is available for all health care professionals. Learn more about this module and other educational opportunities. LinkedInFacebookTwitterEmail this Story
Learn more about DiabetesPro ->DiabetesPro Home  |  Professional Education  |  Journals
Research Grants  |  Recognition Programs  |  Membership

  SmartQuote 
Where there is no imagination there is no horror."
--Sir Arthur Conan Doyle,
Scottish physician and writer


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise
Account Director:  Aaron Kern (202) 407-7866
 
Read more at SmartBrief.com
A powerful website for SmartBrief readers including:
 
 
 Recent DiabetesPro SmartBrief Issues:   Lead Editor:  Kathryn Doherty
     
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2012 SmartBrief, Inc.® Legal Information